vs
Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and FONAR CORP (FONR). Click either name above to swap in a different company.
DYNEX CAPITAL INC is the larger business by last-quarter revenue ($43.5M vs $25.5M, roughly 1.7× FONAR CORP). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs 2.4%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs -0.3%).
Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
DX vs FONR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $43.5M | $25.5M |
| Net Profit | — | $2.1M |
| Gross Margin | — | — |
| Operating Margin | — | 13.5% |
| Net Margin | — | 8.0% |
| Revenue YoY | 531.3% | 2.4% |
| Net Profit YoY | — | 4.7% |
| EPS (diluted) | $1.59 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.5M | $25.5M | ||
| Q3 25 | $30.6M | $26.0M | ||
| Q2 25 | $23.1M | $27.3M | ||
| Q1 25 | $17.1M | $27.2M | ||
| Q4 24 | — | $24.9M | ||
| Q3 24 | — | $25.0M | ||
| Q2 24 | — | $25.9M | ||
| Q1 24 | $-3.2M | $25.7M |
| Q4 25 | — | $2.1M | ||
| Q3 25 | $150.4M | $2.3M | ||
| Q2 25 | $-13.6M | $729.3K | ||
| Q1 25 | $-3.1M | $2.5M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $830.4K | ||
| Q1 24 | $40.1M | $1.9M |
| Q4 25 | — | 13.5% | ||
| Q3 25 | — | 14.1% | ||
| Q2 25 | — | 5.3% | ||
| Q1 25 | — | 15.2% | ||
| Q4 24 | — | 11.9% | ||
| Q3 24 | — | 21.0% | ||
| Q2 24 | — | 7.4% | ||
| Q1 24 | — | 16.8% |
| Q4 25 | — | 8.0% | ||
| Q3 25 | 491.3% | 8.7% | ||
| Q2 25 | -58.8% | 2.7% | ||
| Q1 25 | -18.0% | 9.2% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | — | 12.6% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | -1256.8% | 7.3% |
| Q4 25 | $1.59 | — | ||
| Q3 25 | $1.08 | — | ||
| Q2 25 | $-0.14 | — | ||
| Q1 25 | $-0.06 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $0.64 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $531.0M | $121.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.5B | $176.9M |
| Total Assets | $17.3B | $217.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $531.0M | $121.0K | ||
| Q3 25 | $491.0M | $122.0K | ||
| Q2 25 | $387.5M | $56.5M | ||
| Q1 25 | $327.4M | $123.0K | ||
| Q4 24 | — | $121.0K | ||
| Q3 24 | — | $136.0K | ||
| Q2 24 | — | $56.5M | ||
| Q1 24 | $295.7M | $134.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $66.9K | ||
| Q1 24 | — | — |
| Q4 25 | $2.5B | $176.9M | ||
| Q3 25 | $2.0B | $174.9M | ||
| Q2 25 | $1.6B | $172.6M | ||
| Q1 25 | $1.4B | $171.9M | ||
| Q4 24 | — | $169.8M | ||
| Q3 24 | — | $168.7M | ||
| Q2 24 | — | $166.0M | ||
| Q1 24 | $958.5M | $165.8M |
| Q4 25 | $17.3B | $217.2M | ||
| Q3 25 | $14.2B | $218.4M | ||
| Q2 25 | $11.3B | $216.9M | ||
| Q1 25 | $9.0B | $214.9M | ||
| Q4 24 | — | $208.0M | ||
| Q3 24 | — | $212.3M | ||
| Q2 24 | — | $214.2M | ||
| Q1 24 | $6.3B | $209.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.8M | $171.0K |
| Free Cash FlowOCF − Capex | — | $-227.0K |
| FCF MarginFCF / Revenue | — | -0.9% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | 0.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.8M | $171.0K | ||
| Q3 25 | $68.3M | $1.7M | ||
| Q2 25 | $31.9M | $4.2M | ||
| Q1 25 | $6.4M | $3.1M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $4.6M | ||
| Q1 24 | $-17.1M | $2.8M |
| Q4 25 | — | $-227.0K | ||
| Q3 25 | — | $-177.0K | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $2.6M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | — | $-148.0K | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | — | -0.9% | ||
| Q3 25 | — | -0.7% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | — | 9.4% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | -0.6% | ||
| Q2 24 | — | 16.1% | ||
| Q1 24 | — | 10.2% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | — | 0.08× | ||
| Q3 25 | 0.45× | 0.75× | ||
| Q2 25 | — | 5.79× | ||
| Q1 25 | — | 1.26× | ||
| Q4 24 | — | 1.14× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 5.54× | ||
| Q1 24 | -0.43× | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DX
Segment breakdown not available.
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
